Stay updated on Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check7 days agoChange DetectedThe study details page now displays a 403 Forbidden page, replacing the previous content. This blocks access to the study record and its details.SummaryDifference0.5%

- Check14 days agoChange DetectedThe page now renders a 403 Forbidden error instead of displaying the study details, effectively blocking access to the study record. The layout still shows the site header and footer, indicating a standard error response rather than the study content.SummaryDifference21%

- Check35 days agoChange DetectedRevision: v3.6.6 replaces the previous revision label. It indicates a small update to the site's documentation or interface.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page now includes new study documents and metadata, such as the Informed Consent Form and Study Protocol/Statistical Analysis Plan, plus author/sponsor details and NIH/NCI links, with associated MeSH terms and record history.SummaryDifference63%

- Check57 days agoChange DetectedRevision: v3.6.5 was added and the previous Revision: v3.6.4 was removed. This signals a small update to the page build rather than a change to the study content.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing v3.6.3, indicating a software version update reflected in the page text.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page.